Fundraising FoxCannapharmarx
OTC: CPMDCarneys Point, US · Founded 2014 · Delaware corporation
Find your way into Cannapharmarx
Sign up to see every warm intro you have to Cannapharmarx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cannapharmarx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CannapharmaRx cultivates high-quality medical and craft cannabis from a facility in Cremona, Alberta, with capacity for over 6,000 kg per year and more than 200 genetic strains across 15 brand classes. The company sells in Canada and exports to European markets such as Germany, with plans to expand into Israel.
Founders & leadership
CS
CHRISTOPHER SCHNITTKERExecutive
GC
GERALD CROCKERExecutive
OF
Oliver FoesteCFO
Board
SR
STEVEN RULEBoard director
DP
DAVID POHLBoard director
RL
ROBERT LIESSBoard director
JS
JAMES SMEEDINGBoard director
MS
MATHEW SHERWOODBoard director
GH
GARY HERICKBoard director
AG
ALEX GIAQUINTOBoard director
EK
ELIE KHALIFEBoard director
WD
WENDY DICICCOBoard director
Reported raises · per SEC filings
Form D private placements$39.4M disclosed across 7 of 9 rounds · 1900–2019
▶$167KraisedMar 2019 · 11 investors · OtherRule 506(b)
▶$167KraisedMar 2019 · 11 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- James SamuelsonDirector
- Dominick ColvinExecutive Officer, Director
- Gary HerickExecutive Officer, Director
- Matthew NicosiaDirector
- Offering amount
- $3M
- Amount sold
- $167K
- Minimum investment
- $5K
- Proceeds to insiders
- $300K
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedJan 2019 · 35 investors · OtherRule 506(b)
▶$2.1MraisedJan 2019 · 35 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Gary HerickExecutive Officer, Director
- James SamuelsonExecutive Officer
- Matthew NicosiaDirector
- James SamuelsonDirector
- Offering amount
- $2.5M
- Amount sold
- $2.1M
- Proceeds to insiders
- $281.8K
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$34.1MraisedAug 2015 · 22 investors · PharmaceuticalsRule 506(b)
▶$34.1MraisedAug 2015 · 22 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Wendy DiCiccoDirector
- Steven RuleDirector
- Gerald CrockerExecutive Officer, Director
- Gary HerickDirector
- Mathew SherwoodDirector
- David PohlDirector
- Christopher SchnittkerExecutive Officer
- Elie KhalifeDirector
- Robert LiessDirector
- James SmeedingDirector
- Alex GiaquintoDirector
- Offering amount
- $34.1M
- Amount sold
- $34.1M
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$804.5KraisedAug 2015 · 7 investors · PharmaceuticalsRule 506(b)
▶$804.5KraisedAug 2015 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- STEVEN RULEDirector
- CHRISTOPHER SCHNITTKERExecutive Officer
- DAVID POHLDirector
- GERALD CROCKERExecutive Officer, Director
- ROBERT LIESSDirector
- JAMES SMEEDINGDirector
- MATHEW SHERWOODDirector
- GARY HERICKDirector
- ALEX GIAQUINTODirector
- ELIE KHALIFEDirector
- WENDY DICICCODirector
- Offering amount
- $2.3M
- Amount sold
- $804.5K
- Minimum investment
- $19.5K
- Proceeds to insiders
- $75K
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedJun 2014 · 6 investors · PharmaceuticalsRule 506(b)
▶$500KraisedJun 2014 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- GERRY CROCKERExecutive Officer, Director
- GARY COHENExecutive Officer, Director
- GARY HERICKExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $500K
- Minimum investment
- $5K
- Proceeds to insiders
- $350K
- First sale
- May 2014
- Incorporated
- Corporation, Colorado, 2014
- Federal exemptions
- 06b
▶$1.4MraisedJun 2014 · 22 investors · PharmaceuticalsRule 506(b)
▶$1.4MraisedJun 2014 · 22 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- GARY COHENDirector
- JAMES SMEEDINGDirector
- GARY HERICKExecutive Officer, Director
- ROBERT """BO""" LIESSDirector
- GERRY CROCKERExecutive Officer
- Offering amount
- $3M
- Amount sold
- $1.4M
- Minimum investment
- $5K
- Proceeds to insiders
- $400K
- First sale
- May 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$296KraisedMay 2014 · 1 investors · OtherRule 506(b)
▶$296KraisedMay 2014 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- GARY HERICKExecutive Officer, Director
- DAVID J. CUTLERDirector
- GARY COHENDirector
- REDGIE T. GREENDirector
- GERRY CROCKERExecutive Officer
- Offering amount
- $296K
- Amount sold
- $296K
- Minimum investment
- $296K
- Proceeds to insiders
- $25K
- First sale
- May 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$28.5Mvaluation at IPOMay 2021 · $0.17/share · S-1/A
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Frequently asked questions
- What does Cannapharmarx do?
- CannapharmaRx cultivates high-quality medical and craft cannabis from a facility in Cremona, Alberta, with capacity for over 6,000 kg per year and more than 200 genetic strains across 15 brand classes. The company sells in Canada and exports to European markets such as Germany, with plans to expand into Israel.
- How much funding has Cannapharmarx raised?
- Cannapharmarx has disclosed $39.4M raised across 7 of its 9 known rounds.
- Where is Cannapharmarx headquartered?
- Cannapharmarx is headquartered in Carneys Point, US.